- Respiratory diagnostics are critical tools used for the detection, monitoring, and management of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung infections, and pulmonary fibrosis. These tests include imaging, spirometry, molecular diagnostics, and blood gas analysis
- The rising prevalence of chronic respiratory diseases, increasing air pollution levels, and technological advancements in diagnostic devices are key drivers propelling the respiratory diagnostics market forward
- North America is dominating the respiratory diagnostics market with the largest market share of, 35.90%, driven by its advanced healthcare infrastructure, widespread availability of diagnostic services, and early adoption of innovative testing technologies
- Asia-Pacific is expected to witness the highest growth rate in the respiratory diagnostics market, driven by growing awareness of respiratory health, expanding middle-class populations, and government-led healthcare reform initiatives
- The imaging tests segment is expected to dominate the market with the largest market share of 68.44%, due to the increasing prevalence of chronic diseases, rising demand for non-invasive diagnostic techniques, and continuous advancements in imaging technologies such as MRI, CT, and ultrasound
